HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Ouassima Erefai, Speaker at Cancer Events
Ibn Tofail University, Morocco

Abstract:

As the Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a global health challenge, its impact on vulnerable populations, particularly those with lung neoplasms, has been profound. This systematic review aimed to delineate the range of COVID-19-related complications in this high-risk patient cohort.
Methods: A comprehensive search of databases including PubMed, Scopus, Web of Science, and Science Direct yielded 395 relevant studies published through January 2023. Rigorous criteria led to the selection of twenty studies for in-depth review, focusing on the cataloging of COVID-19-related complications in patients with lung cancer.
Results: Detailed analysis revealed a significant association between COVID-19 and adverse clinical outcomes in patients with lung cancer, marked by a substantial increase in mechanical ventilation needs and intensive care unit admissions. Notably, the concurrent diagnosis of lung cancer and COVID-19 infection was linked with a heightened mortality risk, emphasizing the severity of this dual pathology.
Conclusion: The intersection of COVID-19 and lung cancer accentuates the urgent requirement for proactive, tailored preventive strategies and the creation of integrated treatment protocols. These interventions are vital to mitigate the impact of COVID-19 on this vulnerable patient group and manage the dual threat of this infectious disease and cancer.

Audience Take Away Notes:

  • The synthesized data from the systematic review revealed the significant impact of the COVID-19 pandemic on lung cancer patients. This emphasizes the need for targeted clinical interventions and resource allocation for this vulnerable cohort
  • The increased mortality risk associated with concurrent diagnoses of lung cancer and COVID-19 infection provides a compelling case for the development of integrated care pathways and personalized treatment protocols
  • The findings of this study emphasize the need for healthcare systems and policymakers to prioritize preventive measures for high-risk populations. This could significantly reduce morbidity and mortality in the event of future pandemics or similar health crises

Biography:

Ouassima Erefai is a professor and researcher at High Institute of Nursing Professions and Technical Health and Ibn Tofail University in Morocco. She obtained her Ph.D. in Biology in 2022. Her research focuses particularly on epidemiology, especially on lung cancer and environmental epidemiology. She has many publications and has presented her work at several international conferences.

Watsapp